Why attend
Are you a Danish biotech or a life-science company looking for concrete collaboration opportunities? Join us at Symbion to meet 11 French biotech SMEs who are actively seeking Danish partners for co-development, pilot projects, licensing and commercialisation.
Before the pitches, Bpifrance — France’s public investment bank — will explain how it can co-finance the French partner (loans, guarantees, co-investment) to help de-risk and enable DK–FR projects. Medicon Valley Alliance and Dansk Biotek will frame the Danish ecosystem so visiting companies understand how to engage effectively in Denmark.
What you’ll gain
- Direct partner access: rapid pitches followed by a focused marketplace with company stations for one-to-one discussions.
- Technology & business pathways: explore co-development, PoCs/pilots, licensing, commercial partnerships and scale-up opportunities.
- Financing in play: understand how Bpifrance can support the French side of a joint project (loans, guarantees, co-investment) to make collaborations more feasible.
Who should attend
Primary audience: Danish biotech companies (SMEs, scale-ups, spin-outs).
Also welcome: relevant life science actors and service providers (CRO/CMO, lab-tech, data/AI) and investors interested in early partnership opportunities.
Click here to read more and sign up for the event.
Date: Thursday, 16th October 2025
Time: 12:30 – 16:00
Venue: Symbion (meetingroom K1), Fruebjergvej 3, 2100 Copenhagen Ø, Denmark
Program
| 12:30 | Light lunch & registration |
| 13:00 | Welcome – Erhvervshus Hovedstaden / Enterprise Europe Network |
| 13:15 | The Medicon Valley life science ecosystem – Medicon Valley Alliance |
| 13:30 | Danish biotech SMEs: strengths & collaboration opportunities – Dansk Biotek |
| 13:45 | Bpifrance: international support including financing and loans – Bpifrance |
| 14:00 | Pitch session – 11 French SMEs |
| 14:45 | Coffee & cake and informal networking |
| 16:00 | End of meeting |
Speakers
 |
Hans Schambye serves as Chairman of Danish Biotech, the industry association representing the Danish biotechnology sector. With extensive leadership experience in the life sciences, he is a strong proponent of innovation, research, and growth within biotechnology. In his capacity as Chairman, he is committed to strengthening collaboration between industry, academia, and policymakers, thereby ensuring Denmark’s position as a competitive center for biotechnology. |
 |
David Munis Zepernick is Director of Member Engagement & Communication at Medicon Valley Alliance (MVA), the Danish-Swedish life science cluster in the Øresund region. With solid experience in communication and relationship-building, he works to strengthen collaboration among members, industry stakeholders, and policymakers. He contributes actively to advancing innovation, partnerships, and Denmark’s position as a leading life science region.
|
 |
Paul Jaulin is Export Development Manager at Bpifrance, the French public investment bank supporting French companies with financing and export development. Based in Paris, he is responsible for the development of export activities and international missions, particularly targeting SMEs and mid-sized companies, where he provides support for their international expansion. |